Ischemic Heart Disease. Acute myocardial infarction
Conditions
Interventions
Intervention 1: The second group recieved 80 mg /day Atorvastatin for six months. Intervention 2: The first group recievd 20 mg/day Atorvastating for six months. Intervention 3: The second group recie
Treatment - Drugs
The second group recieved 80 mg /day Atorvastatin for six months
The first group recievd 20 mg/day Atorvastating for six months
The second group recieved 40 mg/day Atorvastatin for six months.
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Inclusion criteria: Male; Stable;Acute Coronary Syndrome;Documented atherosclerotic lesions in Angiography ; Refused to do Coronary Artery Bypass Graft or Angioplasty Exclusion criteris: Female; Unstable Angina; Sensitivity to Statins ; Diseases of hepatobiliary system ; Serum creatinine concentrations =175µmol/l (2.0 mg/dl) ; Left anterior descending artery involvement ; History of using QT interval prolongation and P450 suppressant drugs ; unreasonable high creatine kinase
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Homocysteine levels. Timepoint: 1, 3 and 6 months. Method of measurement: Blood sampling. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of drug. Timepoint: 1,3,6 months and whenever the patients complaint. Method of measurement: Clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSafoora Masoumi
Mazandaran University of Medical Sciences
Outcome results
None listed